U.S. Building Stock News

Easterly Government Properties stock: recent returns and income profile Easterly Government Properties (DEA) has drawn investor attention after a mixed run in its recent returns, with gains over the past month and past 3 months contrasting with weaker one year and multi year performance. See our latest analysis for Easterly Government Properties. The recent 7 day share price return of 4.34% and 30 day gain of 2.05% to around $22.36 sit against a weaker 1 year total shareholder return of...

In early January 2026, President Trump proposed lifting the 2027 U.S. defense budget to about US$1.50 trillion and signed an executive order tying defense contractors’ access to contracts and CEO pay to reinvestment in weapons production rather than dividends or stock buybacks. This policy mix of much higher planned spending and tighter capital-return constraints could reshape how General Dynamics allocates cash between growth projects and shareholder returns. We’ll now examine how the...

Planet Labs PBC recently secured a seven-year satellite contract with an Asia-Pacific partner that has helped it deliver three consecutive quarters of positive free cash flow and significantly expand its order backlog. This shift from cash burn to cash generation suggests that Planet Labs’ business model is maturing, with longer-term contracts providing greater operational visibility and financial resilience. We’ll now explore how Planet Labs’ emergence as a free cash flow generator reshapes...

SentinelOne (S) is back in focus after Piper Sandler moved to a Neutral rating, citing recent management changes, limited near term catalysts, and disappointment with recent company results despite confidence in the security platform. See our latest analysis for SentinelOne. At a share price of $15.12, SentinelOne has seen a 1 day share price return of 1.37% decline and a 90 day share price return of 11.22% decline, while the 1 year total shareholder return of 31.02% decline suggests fading...

Danaher recently announced at the J.P. Morgan Healthcare Conference that it expects fourth-quarter 2025 revenues to grow in the mid-single digit percent range year over year, with non-GAAP core revenue growth tracking toward the high end of its prior low-single digit guidance. The company also pointed to improving industry conditions, including finalized tariff rules and reduced customer inventories, as factors supporting its operational strengths and long-term value focus. We’ll now examine...

Recently, Star Bulk Carriers has been in focus as the Baltic Dry Index retreated sharply over the past month, raising concerns about pressure on near-term freight rates, earnings, and dividends ahead of the company’s fourth-quarter and full-year 2025 results release, scheduled for February 25, 2026. At the same time, analyst expectations for stronger year-over-year earnings and a top Zacks Rank highlight contrasting optimism about Star Bulk’s upcoming performance despite softer industry...

Event context and recent price performance Azenta (AZTA) has drawn investor interest after recent share price moves, with the stock closing at US$37.92 and showing double digit gains over the past 3 months, despite a weaker 1 year total return. See our latest analysis for Azenta. The recent 23.92% 3 month share price return contrasts with a 27.45% decline in 1 year total shareholder return, so momentum has picked up lately even though longer term investors remain under water. If Azenta has...

Renewed attention on Stellar Bancorp (STEL) followed a Raymond James analyst reiterating a positive rating and raising their outlook, with the analyst’s past success rate drawing investor interest. See our latest analysis for Stellar Bancorp. At a share price of US$31.62, Stellar Bancorp has had a fairly steady run recently, with a 1-year total shareholder return of 20.93% contrasting with a modest 2.80% year to date share price return. This suggests momentum that has cooled slightly even as...

Wells Fargo (WFC) is drawing attention as investors position ahead of its January 14 earnings report, with the bank set to help open U.S. earnings season and offer fresh clues on consumer and credit conditions. See our latest analysis for Wells Fargo. The share price sits at US$95.95 after a 13.5% 90 day share price return and a 39.0% total shareholder return over the past year. This suggests interest has been building as investors weigh Wells Fargo's upcoming earnings, recent bond issuance...

Baidu (BIDU) is back in focus after two linked tech moves: a planned spin off of its AI chip arm Kunlunxin via a confidential Hong Kong listing application, and fresh progress in autonomous driving through Apollo Go in Dubai. See our latest analysis for Baidu. The recent 14.82% 30 day share price return and 19.68% 90 day share price return suggest momentum has picked up again, even though the year to date share price return is slightly negative and the 5 year total shareholder return remains...

Enphase Energy (ENPH) has drawn fresh attention after beginning US production shipments of its IQ9N-3P Commercial Microinverter. Recent earnings estimate revisions and a revenue and EPS beat contrast with earlier downgrades and elevated short interest. See our latest analysis for Enphase Energy. The IQ9N-3P launch comes after a mixed period for the stock, with a 30 day share price return of 9.45% and a 1 year total shareholder return decline of 47.33%. This suggests that short term momentum...

President Donald Trump’s directive for Fannie Mae and Freddie Mac to buy up to $200 billion in mortgage backed securities has pushed housing finance into focus, and Federal National Mortgage Association (FNMA) is right at the center of that conversation. See our latest analysis for Federal National Mortgage Association. The share price sits at $11.01 after a modest 1 day share price return of 1.47%. While short term trading has been mixed, the 1 year total shareholder return of about 101%...

Recently, Goodyear introduced its SightLine technology, embedding sensors in tires to deliver real-time road-friction data to autonomous and electric vehicle systems through collaborations with partners such as NVIDIA and autonomous trucking operators. This move highlights how Goodyear is shifting from being only a tire manufacturer toward becoming a data and technology provider to future mobility platforms. We’ll now explore how Goodyear’s push into sensor-enabled, data-rich tires through...

Harmonic (HLIT) has been drawing attention after recent share price moves, with the stock last closing at $9.63. For investors, the key question is how this level lines up with fundamentals. See our latest analysis for Harmonic. Recent moves sit against a weaker backdrop, with a 30 day share price return of a 6.32% decline and a 1 year total shareholder return of a 22.59% loss, suggesting momentum has been fading despite the current US$9.63 level. If Harmonic has you reassessing opportunities...

Comstock Resources, Inc.'s ( NYSE:CRK ) price-to-sales (or "P/S") ratio of 3.5x may not look like an appealing...

In early January 2026, American Electric Power’s unregulated unit finalized a US$2.65 billion purchase of about 900 MW of Bloom Energy’s solid‑oxide fuel cells for a Wyoming power facility, backed by a 20‑year offtake agreement for all its output. This utility‑scale order, one of the largest solid‑oxide fuel cell deployments to date, positions Bloom Energy as a key on‑site power provider for AI‑driven data center demand and long‑term grid‑adjacent generation. Next, we’ll examine how this...

In recent months, SiTime has continued to beat analyst EPS forecasts for four straight quarters, while analysts have raised their expectations for the company’s earnings and revenue in the year ahead, signaling stronger operational performance than previously modeled. This pattern of consistent earnings outperformance combined with upgraded forecasts suggests growing confidence in SiTime’s business momentum among research analysts and institutional investors. Now, we’ll explore how this...

Why Oracle Is On Investors’ Radar Today Oracle (ORCL) has caught investor attention after a mixed run in recent months, with the stock showing a negative past 3 months return but a positive move over the past month and year. See our latest analysis for Oracle. The recent 1-day share price return of 4.68% and 7-day share price return of 3.08% at a last close of $198.52 sit against a weaker 90-day share price return of 33.61% decline. Near term momentum is picking up even though the longer...

Physical AI reorganization puts robotics and autos in focus Arm Holdings (ARM) has created a new Physical AI unit, reshaping its operations around three segments that group automotive and robotics together, while separating cloud and AI, and edge products for phones and PCs. See our latest analysis for Arm Holdings. Arm shares have been under pressure recently, with a 1 month share price return showing a 14.59% decline and a 3 month share price return showing a 33.52% decline. This leaves the...

IonQ recently reported very large year-on-year sales growth and world‑record quantum gate fidelity, while continuing to post widening losses as it invests heavily in research and development. The company’s early completion of its Tempo system milestones, combined with new international deployments such as the KISTI partnership in South Korea, highlights how its technology is beginning to move from lab prototype toward real‑world integration. Next, we’ll examine how IonQ’s industry‑leading...

If you are wondering whether DraftKings is still priced for excitement or starting to offer value, you are not alone. This article is written with that exact question in mind. The stock closed at US$35.17, with recent returns showing a 3% decline over 7 days, a 1% decline over 30 days, a 1.4% decline year to date, an 11.7% decline over 1 year, and a very large gain over 3 years that sits alongside a 34.5% decline over 5 years. Recent headlines around DraftKings have continued to focus on the...

Guardant Health (GH) is back in focus after TRICARE agreed to cover its FDA approved Shield blood test for colorectal cancer screening for active duty U.S. military members and eligible families in Florida. See our latest analysis for Guardant Health. The TRICARE decision and recent revenue update sit against a strong run in the shares, with a 90 day share price return of 76.1% and a 1 year total shareholder return of 189.16%, suggesting momentum has been building despite a weaker 5 year...

Pacira BioSciences recently reported preliminary unaudited 2025 revenue of US$726.4 million, modestly above the prior year’s US$701.0 million, while also completing a US$150.05 million buyback totaling 5,932,106 shares since May 2025. At the same time, the company lowered its 2025 revenue forecast and faced fresh pressure from activist DOMA Perpetual Capital Management, which is pushing for board changes and a potential sale process. Next, we’ll examine how the downward 2025 revenue forecast...

XPEL recently reported past Q3 2025 results with revenue coming in ahead of forecasts even as earnings per share fell short, alongside outlining plans for capital investment and expansion. This combination of stronger-than-expected sales and a clearer roadmap for growth and margins has reinforced investor attention on the company’s operating trajectory. We’ll now examine how stronger-than-expected revenue growth, despite an earnings miss, may influence XPEL’s broader investment narrative and...